News

Notice of Change of President

Our researcher participated in writing a feature article for the December 2019 issue of the monthly magazine “PHARM STAGE”.

The following monthly magazine, in which our researcher participated in writing, has been published. Book: PHARM STAGE Monthly, December 2019 Publication date: December 27, 2019 Theme: [Special Feature] M...

A book in which our researchers participated in writing has been published.

The following books, in which our researchers participated in writing, have been published.。   Book: Procedures for Implementing Technology Transfer (Test Method, Manufacturing Process) and Ensurin...

Our researcher’s article featured in the August 2019 issue of Synfacts

Two papers by our researchers (research at Takeda Pharmaceutical Sciences) were featured in the August issue of Synfacts, a professional journal that selects and introduces outstanding research from among the ...

Our Researchers present Research at ACS National Meeting, August 25-29, 2019 in San Diego, CA

Two of our researchers from Chemical R&D Division presented at the ACS National Meeting held in San Diego, USA, August 25-29, 2019. Our technologies and experiences in API process research and developme...

Exhibited at the International Symposium on Process Chemistry  (July 24-26, 2019, Kyoto International Conference Center)

SPERA PHARMA had a booth at the International Symposium on Process Chemistry held at the Kyoto International Conference Center for three days from Wednesday, July 24 to Friday, July 26, 2019. Thank you very mu...

SPERA PHARMA had a booth at the 1st PharmaLab Expo , which was held at Tokyo Big Sight Aomi Exhibition Hall for three days from Wednesday, July 3 to Friday, July 5, 2019. Thank you very much for stopping by o...

 Akira Horinouchi(Director , Legal Affairs and Facility Management Department), who is in charge of PDE and exposure control level setting in our company, co-authored a paper on PDE setting as follows. Titl...

Business Collaboration in Biopharmaceutical Development

Kishi Kasei Co., Ltd. (President: Daisuke Maezawa) and SPERA PHARMA, Inc. (President: Toshio Yoshioka) have agreed to a business collaboration combining Kishi Kasei’s contract manufacturing of Biomaterials and...

Poster presentation at 4th International Symposium for Medicinal Sciences (ISMS)

At the 4th International Symposium for Medicinal Sciences held on March 27, at Kanazawa Art Hall/Kanazawa Motenashi Dome during the 138th Annual Meeting of The Pharmaceutical Society of Japan (March 25 - 28), ...

MORE

now loading.

page top